Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.

Source:http://linkedlifedata.com/resource/pubmed/id/21118739

Download in:

View as

General Info

PMID
21118739